Does ROSUVASTATIN Cause Injection site haemorrhage? 129 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Injection site haemorrhage have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.4% of all adverse event reports for ROSUVASTATIN.
129
Reports of Injection site haemorrhage with ROSUVASTATIN
0.4%
of all ROSUVASTATIN reports
0
Deaths
8
Hospitalizations
How Dangerous Is Injection site haemorrhage From ROSUVASTATIN?
Of the 129 reports, 8 (6.2%) required hospitalization.
Is Injection site haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Injection site haemorrhage?
ADALIMUMAB (11,715)
EXENATIDE (5,527)
ETANERCEPT (4,674)
TIRZEPATIDE (4,389)
EVOLOCUMAB (3,720)
DULAGLUTIDE (3,028)
TERIPARATIDE (2,330)
GALCANEZUMAB-GNLM (1,415)
DUPILUMAB (1,401)
HUMIRA (1,304)
Which ROSUVASTATIN Alternatives Have Lower Injection site haemorrhage Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN